Levamisole as a Strategy Against Bacteria from Canine Otitis Externa: An In Vitro Evaluation

Canine otitis externa is a prevalent condition, and inadequate treatment may favor the emergence of multidrug-resistant microorganisms. Drug repurposing provides an alternative approach for the management of this disease. Thus, this study aimed at assessing the antimicrobial and antibiofilm properti...

Full description

Saved in:
Bibliographic Details
Main Authors: Rodrigo F. M. Guedes, Ana C. C. F. Soares, Francisco I. F. Gomes, Alyne S. Freitas, Vinicius C. Pereira, Rossana A. Cordeiro, Marcos F. G. Rocha, José J. C. Sidrim, Giovanna R. Barbosa, Glaucia M. M. Guedes, Debora S. C. M. Castelo-Branco
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Veterinary Sciences
Subjects:
Online Access:https://www.mdpi.com/2306-7381/12/7/640
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850071879120846848
author Rodrigo F. M. Guedes
Ana C. C. F. Soares
Francisco I. F. Gomes
Alyne S. Freitas
Vinicius C. Pereira
Rossana A. Cordeiro
Marcos F. G. Rocha
José J. C. Sidrim
Giovanna R. Barbosa
Glaucia M. M. Guedes
Debora S. C. M. Castelo-Branco
author_facet Rodrigo F. M. Guedes
Ana C. C. F. Soares
Francisco I. F. Gomes
Alyne S. Freitas
Vinicius C. Pereira
Rossana A. Cordeiro
Marcos F. G. Rocha
José J. C. Sidrim
Giovanna R. Barbosa
Glaucia M. M. Guedes
Debora S. C. M. Castelo-Branco
author_sort Rodrigo F. M. Guedes
collection DOAJ
description Canine otitis externa is a prevalent condition, and inadequate treatment may favor the emergence of multidrug-resistant microorganisms. Drug repurposing provides an alternative approach for the management of this disease. Thus, this study aimed at assessing the antimicrobial and antibiofilm properties of levamisole against bacterial strains recovered from dogs with otitis externa as well as its influence on biofilm growth dynamics during 120 h. A total of 50 clinical bacterial isolates were subjected to analysis. Planktonic bacterial susceptibility to levamisole was assessed by broth microdilution to determine the minimum inhibitory concentration (MIC), the lowest concentration that completely inhibits bacterial growth. The activity against mature biofilms was assessed by determining the minimum biofilm eradication concentration (MBEC). The effect of levamisole on biofilm formation was evaluated at the MIC and at two subinhibitory concentrations, with daily readings recorded at 48, 72, 96, and 120 h. MICs of levamisole ranged from 0.58 to 2.34 mg/mL. Levamisole reduced the biomass of mature biofilms (<i>p</i> < 0.05), with MBEC values ranging from 1.17 to 18.75 mg/mL, and biofilm formation was significantly reduced at the MIC concentration (1.17 mg/mL) for all isolates for 120 h (<i>p</i> < 0.05). Levamisole demonstrated potential as a preventive approach against biofilm-associated bacterial otitis.
format Article
id doaj-art-b0166886c3c04f7ca4b7b0aaa21c384f
institution DOAJ
issn 2306-7381
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Veterinary Sciences
spelling doaj-art-b0166886c3c04f7ca4b7b0aaa21c384f2025-08-20T02:47:13ZengMDPI AGVeterinary Sciences2306-73812025-07-0112764010.3390/vetsci12070640Levamisole as a Strategy Against Bacteria from Canine Otitis Externa: An In Vitro EvaluationRodrigo F. M. Guedes0Ana C. C. F. Soares1Francisco I. F. Gomes2Alyne S. Freitas3Vinicius C. Pereira4Rossana A. Cordeiro5Marcos F. G. Rocha6José J. C. Sidrim7Giovanna R. Barbosa8Glaucia M. M. Guedes9Debora S. C. M. Castelo-Branco10Course of Veterinary Medicine, Education, Sciencies and Technology Center of the Inhamuns Region, State University of Ceará, Tauá 63660-000, CE, BrazilCourse of Veterinary Medicine, University of Fortaleza, Fortaleza 60811-905, CE, BrazilGroup of Applied Medical Microbiology, Post-Graduate Program in Medical Microbiology, Federal University of Ceará, Fortaleza 60420-270, CE, BrazilGroup of Applied Medical Microbiology, Post-Graduate Program in Medical Microbiology, Federal University of Ceará, Fortaleza 60420-270, CE, BrazilGroup of Applied Medical Microbiology, Post-Graduate Program in Medical Microbiology, Federal University of Ceará, Fortaleza 60420-270, CE, BrazilLaboratory of Infectious Bioagents, Post-Graduate Program in Medical Microbiology, Federal University of Ceará, Fortaleza 60420-270, CE, BrazilPost-Graduate Program in Veterinary Sciences, College of Veterinary, State University of Ceará, Fortaleza 60714-903, CE, BrazilSpecialized Medical Mycology Center, Post-Graduate Program in Medical Microbiology, Federal University of Ceará, Fortaleza 60420-270, CE, BrazilGroup of Applied Medical Microbiology, Post-Graduate Program in Medical Microbiology, Federal University of Ceará, Fortaleza 60420-270, CE, BrazilGroup of Applied Medical Microbiology, Post-Graduate Program in Medical Microbiology, Federal University of Ceará, Fortaleza 60420-270, CE, BrazilGroup of Applied Medical Microbiology, Post-Graduate Program in Medical Microbiology, Federal University of Ceará, Fortaleza 60420-270, CE, BrazilCanine otitis externa is a prevalent condition, and inadequate treatment may favor the emergence of multidrug-resistant microorganisms. Drug repurposing provides an alternative approach for the management of this disease. Thus, this study aimed at assessing the antimicrobial and antibiofilm properties of levamisole against bacterial strains recovered from dogs with otitis externa as well as its influence on biofilm growth dynamics during 120 h. A total of 50 clinical bacterial isolates were subjected to analysis. Planktonic bacterial susceptibility to levamisole was assessed by broth microdilution to determine the minimum inhibitory concentration (MIC), the lowest concentration that completely inhibits bacterial growth. The activity against mature biofilms was assessed by determining the minimum biofilm eradication concentration (MBEC). The effect of levamisole on biofilm formation was evaluated at the MIC and at two subinhibitory concentrations, with daily readings recorded at 48, 72, 96, and 120 h. MICs of levamisole ranged from 0.58 to 2.34 mg/mL. Levamisole reduced the biomass of mature biofilms (<i>p</i> < 0.05), with MBEC values ranging from 1.17 to 18.75 mg/mL, and biofilm formation was significantly reduced at the MIC concentration (1.17 mg/mL) for all isolates for 120 h (<i>p</i> < 0.05). Levamisole demonstrated potential as a preventive approach against biofilm-associated bacterial otitis.https://www.mdpi.com/2306-7381/12/7/640canine external otitisbacteriabiofilmslevamisole
spellingShingle Rodrigo F. M. Guedes
Ana C. C. F. Soares
Francisco I. F. Gomes
Alyne S. Freitas
Vinicius C. Pereira
Rossana A. Cordeiro
Marcos F. G. Rocha
José J. C. Sidrim
Giovanna R. Barbosa
Glaucia M. M. Guedes
Debora S. C. M. Castelo-Branco
Levamisole as a Strategy Against Bacteria from Canine Otitis Externa: An In Vitro Evaluation
Veterinary Sciences
canine external otitis
bacteria
biofilms
levamisole
title Levamisole as a Strategy Against Bacteria from Canine Otitis Externa: An In Vitro Evaluation
title_full Levamisole as a Strategy Against Bacteria from Canine Otitis Externa: An In Vitro Evaluation
title_fullStr Levamisole as a Strategy Against Bacteria from Canine Otitis Externa: An In Vitro Evaluation
title_full_unstemmed Levamisole as a Strategy Against Bacteria from Canine Otitis Externa: An In Vitro Evaluation
title_short Levamisole as a Strategy Against Bacteria from Canine Otitis Externa: An In Vitro Evaluation
title_sort levamisole as a strategy against bacteria from canine otitis externa an in vitro evaluation
topic canine external otitis
bacteria
biofilms
levamisole
url https://www.mdpi.com/2306-7381/12/7/640
work_keys_str_mv AT rodrigofmguedes levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation
AT anaccfsoares levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation
AT franciscoifgomes levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation
AT alynesfreitas levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation
AT viniciuscpereira levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation
AT rossanaacordeiro levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation
AT marcosfgrocha levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation
AT josejcsidrim levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation
AT giovannarbarbosa levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation
AT glauciammguedes levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation
AT deborascmcastelobranco levamisoleasastrategyagainstbacteriafromcanineotitisexternaaninvitroevaluation